Restructuring Addiction Care Access in Carceral Population and System

Club Drugs | Morton

Course outline

Course progress

Not started
2024 Board Exam Preparation: Pre-Assessment
Open/Close details
- Optional
Not started
Navigating Pain Management: The Role of Buprenorphine and Methadone Amidst the Opioid Crisis | 3 CME Credits
Open/Close details
- Optional
Not started
Train the Trainer: Develop and Implement a Destigmatization Workshop for Your Clinical and Administrative Staff | 3 CME Credits
Open/Close details
- Optional
Not started
Shifting Paradigms: Navigating Psychedelic Therapy in Mental Health and Addiction | 3 CME Credits
Open/Close details
- Optional
Not started
Motivational Interviewing for Busy Clinicians and Educators | 3.75 CME Credits
Open/Close details
- Optional
Not started
Keynote: Neurobiology of Addiction Redefined: Social Determinants on Genetic Vulnerability
Open/Close details
- Optional
Not started
Harm Reduction by Maia Szalavitz | Moderated by Chwen-Yuen Angie Chen, MD, FACP, FASAM
Open/Close details
- Optional
Not started
Opioids: Long-acting Buprenorphine and Overdose Prevention for Unhoused in Fentanyl Era: A Street Medicine Approach
Open/Close details
- Optional
Not started
Restructuring Addiction Care Access in Carceral Population and System
Open/Close details
- Optional
Not started
Women and Addiction Team Lily: Rebecca Schwartz, MSW | Dana Lazarovitz, PHN Teresa Rondone, Navigator | Caitlin Felden-Heimer,
Open/Close details
- Optional
Not started
SUD in Transgender and Nonbinary Individuals | Jackie Alba-Nguyen, MD MPH
Open/Close details
- Optional
Not started
Youth and Substance Use | Veronika Mesheriakova, MD
Open/Close details
- Optional
Not started
Stimulants: Statewide Roll-Out of Contingency Management Programs for Stimulant Use
Open/Close details
- Optional
Not started
Smoking Cessation Intervention in Homeless and Marginally Housed Persons Maya Vijayaraghavan, MD, MAS
Open/Close details
- Optional
Not started
Changing DEA Telehealth/Stimulant Access (ADHD) / Dark Web Element, Prescription Stimulants Shortage and Increased Risk for Illi
Open/Close details
- Optional
Not started
Psychedelics | Anna Lembke, MD | Brian Anderson, MD | Danielle Nova
Open/Close details
- Optional
Not started
Cannabis & Psychedelics: Policy Landscape and Public Health Impacts | Beau Kilmer, PhD
Open/Close details
- Required
Not started
Broadening the Scope: Should Methadone Remain Siloed to OTPs? Scott Steiger, MD | Hillary Kunis, MD
Open/Close details
- Required
Not started
Knowledge Check: 2023 Board Exam Preparation Assessment
Open/Close details
- Required
Not started
Evaluations
Open/Close details
- Required
Not started
Credit
Open/Close details
- Optional
Not started
Certificate
Open/Close details
- Optional

Expand / Minimize

CSAM Education Center

2024 Addiction Medicine Board Exam Preparation Course

Restructuring Addiction Care Access in Carceral Population and System

2024 Board Exam Preparation: Pre-Assessment

Navigating Pain Management: The Role of Buprenorphine and Methadone Amidst the Opioid Crisis | 3 CME Credits

Train the Trainer: Develop and Implement a Destigmatization Workshop for Your Clinical and Administrative Staff | 3 CME Credits

Shifting Paradigms: Navigating Psychedelic Therapy in Mental Health and Addiction | 3 CME Credits

Motivational Interviewing for Busy Clinicians and Educators | 3.75 CME Credits

Keynote: Neurobiology of Addiction Redefined: Social Determinants on Genetic Vulnerability

Harm Reduction by Maia Szalavitz | Moderated by Chwen-Yuen Angie Chen, MD, FACP, FASAM

Opioids: Long-acting Buprenorphine and Overdose Prevention for Unhoused in Fentanyl Era: A Street Medicine Approach

Restructuring Addiction Care Access in Carceral Population and System

Women and Addiction Team Lily: Rebecca Schwartz, MSW | Dana Lazarovitz, PHN Teresa Rondone, Navigator | Caitlin Felden-Heimer,

SUD in Transgender and Nonbinary Individuals | Jackie Alba-Nguyen, MD MPH

Youth and Substance Use | Veronika Mesheriakova, MD

Stimulants: Statewide Roll-Out of Contingency Management Programs for Stimulant Use

Smoking Cessation Intervention in Homeless and Marginally Housed Persons Maya Vijayaraghavan, MD, MAS

Changing DEA Telehealth/Stimulant Access (ADHD) / Dark Web Element, Prescription Stimulants Shortage and Increased Risk for Illi

Psychedelics | Anna Lembke, MD | Brian Anderson, MD | Danielle Nova

Cannabis & Psychedelics: Policy Landscape and Public Health Impacts | Beau Kilmer, PhD

Broadening the Scope: Should Methadone Remain Siloed to OTPs? Scott Steiger, MD | Hillary Kunis, MD

Knowledge Check: 2023 Board Exam Preparation Assessment

Evaluations

Credit

Certificate

Course navigation

You are here

2024 Addiction Medicine Board Exam Preparation Course

Restructuring Addiction Care Access in Carceral Population and System

2024 Board Exam Preparation: Pre-Assessment

Navigating Pain Management: The Role of Buprenorphine and Methadone Amidst the Opioid Crisis | 3 CME Credits

Train the Trainer: Develop and Implement a Destigmatization Workshop for Your Clinical and Administrative Staff | 3 CME Credits

Shifting Paradigms: Navigating Psychedelic Therapy in Mental Health and Addiction | 3 CME Credits

Motivational Interviewing for Busy Clinicians and Educators | 3.75 CME Credits

Keynote: Neurobiology of Addiction Redefined: Social Determinants on Genetic Vulnerability

Harm Reduction by Maia Szalavitz | Moderated by Chwen-Yuen Angie Chen, MD, FACP, FASAM

Opioids: Long-acting Buprenorphine and Overdose Prevention for Unhoused in Fentanyl Era: A Street Medicine Approach

Restructuring Addiction Care Access in Carceral Population and System

Women and Addiction Team Lily: Rebecca Schwartz, MSW | Dana Lazarovitz, PHN Teresa Rondone, Navigator | Caitlin Felden-Heimer,

SUD in Transgender and Nonbinary Individuals | Jackie Alba-Nguyen, MD MPH

Youth and Substance Use | Veronika Mesheriakova, MD

Stimulants: Statewide Roll-Out of Contingency Management Programs for Stimulant Use

Smoking Cessation Intervention in Homeless and Marginally Housed Persons Maya Vijayaraghavan, MD, MAS

Changing DEA Telehealth/Stimulant Access (ADHD) / Dark Web Element, Prescription Stimulants Shortage and Increased Risk for Illi

Psychedelics | Anna Lembke, MD | Brian Anderson, MD | Danielle Nova

Cannabis & Psychedelics: Policy Landscape and Public Health Impacts | Beau Kilmer, PhD

Broadening the Scope: Should Methadone Remain Siloed to OTPs? Scott Steiger, MD | Hillary Kunis, MD

Knowledge Check: 2023 Board Exam Preparation Assessment

Evaluations

Credit

Certificate

Course navigation